Preferred and Common Stock

12 Months Ended

Apr. 30, 2025

Share-Based Payment Arrangement [Abstract]

PREFERRED AND COMMON STOCK

Preferred stock: The Company has 1,000,000 authorized shares of preferred stock, of which 250,000 shares have been designated as Series A Serial Preferred Stock. No shares of preferred stock have been issued.

Common stock: The Company currently has 120,000,000 authorized shares of common stock.

Stock incentive plans: The 2018 Stock Incentive Plan (the “2018 Plan”) was approved by the Company's shareholders on September 5, 2018. Awards under the 2018 Plan may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units and other equity-based and equity-related awards. Each share issued pursuant to a stock option and each share with respect to which a stock-settled stock appreciation right is exercised (regardless of the number of shares actually

delivered) is counted as one share against the maximum limit under the 2018 Plan, and each share issued pursuant to an award of restricted stock or restricted stock units is counted as two shares against the maximum limit. Restricted stock is transferred immediately upon grant (and may be subject to a holding period), whereas restricted stock units have a vesting period that must expire, and in some cases performance or market conditions that must be satisfied before the stock is transferred. At April 30, 2025, there were 949,238 shares available for grant under the 2018 Plan.

We account for share-based compensation by estimating the grant date fair value of time-based and performance-based restricted stock unit awards using the closing price of our common stock on the applicable grant date, or the date on which performance goals for performance-based units are established, if after the grant date. The time-based awards most commonly vest ratably over a three-year period commencing on the first anniversary of the grant date. The performance-based awards represent a “target” amount; the final amount earned is based on the satisfaction of certain performance measures over a three-year performance period and will range from 0% to 200% of “target." The performance-based awards are also subject to the TSR Modifier (see Note 1 for additional information). The fair value of these awards is determined using a Monte Carlo simulation as of the date of the grant. For market-based awards, the share-based compensation expense will not be adjusted should the target awards vary from actual awards.

We recognize these amounts as an operating expense in our consolidated statements of income ratably over the requisite service period using the straight-line method, as adjusted for certain retirement provisions, and updated estimates of shares to be issued under performance-based awards. All awards have been granted at no cost to the grantee.

The following table presents a summary of our restricted stock unit activity during the three-year period ended April 30, 2025. At April 30, 2025, there were no stock options, stock appreciation rights or other equity-based awards outstanding.


		Weighted-Average
		Grant Date Fair
	Shares	Value per Share
Unvested at April 30, 2022	526,394
Granted	165,024	$	218
Vested	(233,533)
Forfeited	(40,773)
Performance Award Adjustments	133,728
Unvested at April 30, 2023	550,840
Granted	142,865	238
Vested	(219,752)
Forfeited	(17,534)
Performance Award Adjustments	35,443
Unvested at April 30, 2024	491,862	229
Granted	113,009	345
Vested	(179,536)	223
Forfeited	(9,540)	255
Performance Award Adjustments	83,448	257
Unvested at April 30, 2025	499,243	$	262

Total share-based compensation costs recorded for employees and non-employee board members for the restricted stock unit awards for the years ended April 30, 2025, 2024 and 2023 were $47,732, $41,379, and $47,024, respectively. As of April 30, 2025, there was $41,299 of total unrecognized compensation costs related to the 2018 Plan for costs related to restricted stock units which are expected to be recognized ratably through fiscal 2028, with a weighted average remaining term of 0.8 year. The fair value of restricted stock unit awards vested for the years ended April 30, 2025, 2024 and 2023 were $65,947, $49,631, and, $46,943, respectively, as of the applicable vest date.

On, and effective as of, March 3, 2022, the Board authorized a share repurchase program, whereby the Company was authorized to repurchase its outstanding common stock from time-to-time, for an aggregate amount of up to $400 million, exclusive of fees, commissions or other costs (the "Repurchase Program"). The Repurchase Program has no set expiration date. The timing and number of repurchase transactions depends on a variety of factors including, but not limited to, market conditions, corporate considerations, business opportunities, debt agreements, and regulatory requirements. The Repurchase Program can be suspended or discontinued at any time. As of April 30, 2025, $295.1 million remained available for future purchases under this share repurchase program. The Company did not complete any share repurchases during the current fiscal year.